Comments on: Rituximab Plus Axi-Cel Induced High Response Rates in Large B-Cell Lymphoma

Comments on: Rituximab Plus Axi-Cel Induced High Response Rates in Large B-Cell Lymphoma https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/american-society-of-clinical-oncology-asco/asco-2022/rituximab-axi-cel-lymphoma-lbcl-high-response-rate-treatment-risk/ Wed, 15 Jun 2022 14:26:38 +0000 hourly 1 https://wordpress.org/?v=6.4.3